Clinical trials in Tilburg – page 24

599 clinical trials in Tilburg, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Tilburg at a glance

599

clinical trials

Research sites1

Quick filters

599 trials in Tilburg

Open in trial search

Anal fistula+2

Not yet recruiting

Study on Antibiotic Treatment with Metronidazole and Ciprofloxacin for Patients with Perianal Abscess After Surgery

Registered drug

Study on Antibiotic Treatment with Metronidazole and Ciprofloxacin for Patients with Perianal Abscess After Surgery

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ciprofloxacin
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Drug use disorder

Not yet recruiting

Study on Baclofen for Inpatient Detoxification in Patients with GHB Use Disorder

Registered drugNo placebo

Study on Baclofen for Inpatient Detoxification in Patients with GHB Use Disorder

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Baclofen
Sponsor:Stichting Radboud universitair medisch centrum

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Study on Cobicistat, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Registered drugNo placebo

Study on Cobicistat, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Dementia Alzheimer's type

Not yet recruiting

Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease

Investigational

Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Prinnovation GmbH

Contact Research Centre

Relapsing multiple sclerosis+2

Not yet recruiting

Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

Registered drug

Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Teriflunomide
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Ischaemic stroke+1

Not yet recruiting

Study on Stopping Atorvastatin in Frail Patients Aged 70+ with Recent Ischemic Stroke or Transient Ischemic Attack

Registered drugNo placebo

Study on Stopping Atorvastatin in Frail Patients Aged 70+ with Recent Ischemic Stroke or Transient Ischemic Attack

Registered drugNo placebo

The Netherlands

Participants:65+ years
Substances:Atorvastatin
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Eli Lilly & Co.

Contact Research Centre

Renal cell carcinoma

Not yet recruiting

Study comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer

Registered drugNo placebo

Study comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Nivolumab
Sponsor:Exelixis Inc.

Contact Research Centre

Colorectal cancer+1

Not yet recruiting

Study on Irinotecan and mFOLFOX4-Bevacizumab for Patients with Resectable Colorectal Peritoneal Metastases

Registered drugNo placebo

Study on Irinotecan and mFOLFOX4-Bevacizumab for Patients with Resectable Colorectal Peritoneal Metastases

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Colitis ulcerative

Not recruiting

Evaluation of Long-Term Efficacy and Safety of Obefazimod as Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis

Investigational

Evaluation of Long-Term Efficacy and Safety of Obefazimod as Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Obefazimod
Sponsor:Abivax

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Hypertension

Not recruiting

Study on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

Registered drug

Study on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Lorundrostat
Sponsor:Mineralys Therapeutics Inc.

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 101 cities in the Netherlands

Clinical research in Tilburg

What the registry says about research in the country

01 Gastrointestinal Diseases

Research focusing on innovative treatments for inflammatory bowel diseases, particularly evaluating new therapies for Crohn's Disease and Ulcerative Colitis. Studies include long-term safety assessments and combination therapy approaches.

Ulcerative Colitis Treatment Studies
Crohn's Disease Management
Gastric Cancer Interventions

Advanced clinical trials examining novel therapeutic agents and their effectiveness in treating moderate to severe digestive conditions.

02 Cardiovascular Research

Comprehensive studies addressing cardiovascular disease management, including investigations into peripheral arterial disease and innovative approaches to reducing cardiovascular events.

Lipoprotein Management
Arterial Disease Treatment
Stroke Prevention Studies

Trials focusing on both preventive measures and treatment strategies for various cardiovascular conditions.

03 Oncology Studies

Innovative research in cancer treatment, including breast cancer, colorectal cancer, and advanced therapeutic approaches for various tumor types.

Breast Cancer Therapies
Colorectal Cancer Treatment
Leukemia Management

Studies evaluating targeted therapies and combination treatments for various stages of cancer.

04 Immunology and Inflammation

Research examining autoimmune conditions and inflammatory disorders, with particular focus on novel therapeutic approaches and long-term disease management.

Rheumatic Disease Studies
Immunotherapy Trials
Anti-inflammatory Treatments

Investigations into innovative treatment options for chronic inflammatory conditions.

Back to the Netherlands All countries